Search

Bring on the science superstars: In an age when schoolchildren are obsessed with celebrity, they need to see science creates heroes too, writes Dave Madden.

Small start-ups can do big things when they know both their limitations and opportunities, says Neville McClenaghan, the co-founder of University of Ulster spin-out Diabetica Ltd.

Beyond its blockbuster drugs Genentech has a commodity rare in a large company – an entrepreneurial culture. Can Roche preserve this?

A quietly published review has criticised FP6 as too bureaucratic, and for not reaching out to the private sector. But are these failings being perpetuated in FP7?